NOX 7.14% 13.0¢ noxopharm limited

Don't worry to much VR. The active ingredient in the drug they...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,852 Posts.
    lightbulb Created with Sketch. 2536
    Don't worry to much VR. The active ingredient in the drug they claim that works is idronoxil an old drug that no longer has any patent rights created way back in the 90's. What most investors are falling to note is that Idronoxil is not used in any treatments at all even after 23 years after its IP grant. And even right now they are pushing uphill to get any US or international patent grants. In fact they are hoping on new data to save the day for them. It is a joke. Even Japan has initially said no. Why would any large pharm pay for a drug they can buy of the shelf right now and use with impunity. Good to see the boys are still holding the line that a phase I trial is somehow the equal of phase II trial. And your right it is utter bullsh%$ to compare a phase I trial with a phase II/III trial. In fact it is a joke. That is what make this page so much fun,,,,,the endless jokes. keep the blow touch on this one VR.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.